NCT02160925View on ClinicalTrials.gov

Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Clinical T1 Renal Mass
Interventions
OTHER

Preoperative 99mTc-Sestamibi SPECT/CT

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT02160925 - Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma | Biotech Hunter | Biotech Hunter